Maximising the ability to identify a potential blockbuster drug has never been so important in the Pharmaceutical industry.  With many of the hugely successful drugs from the 90's coming to the end of their patents, the pressure is on to develop the next big hit.  This has meant the design of strong lead compounds is a must, and new strategies are being developed for this wherever possible. SMi's 9th Annual Advances and Progress in Drug Design conference aims to address the latest developments in drug design and offer tangible examples of these processes in practise.  Attended by senior representatives from all the leading pharmaceutical companies this conference allows you to stay ahead of the game in drug design. For sponsorship opportunities please email sponsorshipdept@smi-online.co.uk     HEAR the latest developments in computational drug design DISCOVER structure based techniques for compound design LEARN from your peers the methods that work, and those that don't       Paul Leeson Director of Medicinal Chemistry AstraZeneca Jonathan Mason Chief Scientist & Head, Computational Chemistry Lundbeck Research & Heptares Therapeutics Paul Bamborough Section Head: Computational Chemistry GlaxoSmithKline

Chris Murray VP, Discovery Technology Astex Therapeutics Romano Kroemer Head, Drug Design Sanofi-Aventis Robert Glen Director of Chemistry, Unilever Centre for Molecular Informatics Cambridge University Chris Phillips Senior Principle Scientist Pfizer Global Research and Development   See the full lineup...

Delegates at SMi's 8th Annual Advances and Progress in Drug Design Conference, 2009 included:

Accelrys Astex Therapeutics F. Hoffmann-La Roche Lundbeck Merck Novartis Pharma Pfizer Sanofi-Aventis AstraZeneca Aureus Pharma Barts & London Sch Of Medicine BAYER BioFocus Boston University Bristol-Myers Squibb Bulgarian Organized Research Activities (BORA) Cambridge Biomedica Cambridge Crystallographic Data Centre Chemical Computing Group Evotec Faculty of Pharmacy Galapagos GlaxoSmithKline

Heptares Therapeutics Inhibox Institut de Recherches Servier Institute of Cancer Research Japan Tobacco Kyowa Hakko Kirin UK Life Chemicals Muscagen National Institute Of Advanced Industrial Science And Technology Neutec Pharma OSI Prosidion Pharmaceutical Quality Matters Pro Metic Life Sciences Prosarix Schrodinger Simulations Plus Takeda Pharmaceutical Company Thomson Scientific Treweren Consultants Tripos Associates University Of Campinas University of Kuopio Vernalis

Crowne Plaza St James London   . 45-51 Buckingham Gate London   SW1E 6AF   Tel: +44 (0) 207 834 6655 Fax: +44 (0) 207 834 6307   www.london.crowneplaza.com

. .

The hotel boasts three excellent restaurants. Bistro 51 with British and European cuisine, the Michelin Starred Indian restaurant Quilon serving south coastal Indian food and Bank Westminster with a modern British menu.  A beautiful, award-winning, courtyard garden surrounds the Victorian buildings of the Crowne Plaza London St James - a peaceful oasis in the centre of London.
 
Nearest train stations:
• Victoria Station, 7 minutes’ walk
• Waterloo Station, 10 minutes by car

Underground stations
• St James’s Park, 5 minutes’ walk (District and Circle lines)
• Victoria Station, 7 minutes' walk (Victoria, District and Circle lines)

SMi discounted rates include Continental Breakfast & VAT
£ 205.63 / Standard room / night for single occupancy
£ 229.13 Executive  room / night for single occupancy

Book your accommodation at SMi discounted rates by calling us on +44 (0)870 9090 713, sending a fax to +44 (0)870 9090 714 or emailing hotels@smi-online.co.uk.